Reduced concentrations of N-acetylaspartate (NAA) and the NAA-creatine ratio in the basal ganglia in bipolar disorder: A study using 3-Tesla proton magnetic resonance spectroscopy

Psychiatry Research - Neuroimaging

Volumn 154, Issue 3, 2007, Pages 259-265

  Frye, Mark A ^a   Thomas, M Albert ^a   Yue, Kenneth ^a   Binesh, Nader ^a   Davanzo, Pablo ^a   Ventura, Joseph ^a   O'Neill, Joseph ^a   Guze, Barry ^a   Curran, John G ^a   Mintz, Jim ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Basal ganglia; Magnetic; Mania; N acetylaspartate; Resonance; Spectroscopy

Indexed keywords

CREATINE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BASAL GANGLION; BIPOLAR DISORDER; CALCULATION; CINGULATE GYRUS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HOSPITALIZATION; HUMAN; MALE; MANIA; METABOLITE; NEUROIMAGING; OCCIPITAL LOBE; PARIETAL LOBE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURED INTERVIEW; WHITE MATTER;

ADULT; ASPARTIC ACID; BASAL GANGLIA; BIPOLAR DISORDER; CREATINE; FEMALE; HOSPITALIZATION; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; OCCIPITAL LOBE; PARIETAL LOBE; PROTONS;

EID: 33947221025     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2006.11.003     Document Type: Article

References (39)

1. Altshuler L.L. Bipolar disorder: are repeated episodes associated with neuroanatomic and cognitive changes?. Biological Psychiatry 33 (1993) 563-565
2. Baslow M.H. N-acetylaspartate in the vertebrate brain: metabolism and function. Neurochemistry Research 28 (2003) 941-953
3. Bertolino A., Frye M., Callicott J.H., Mattay V.S., Rakow R., Shelton-Repella J., Post R., and Weinberger D.R. Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging. Biological Psychiatry 53 (2003) 906-913
4. Blasi G., Bertolino A., Budaglio F., Sciota D., Altamora M., Antonucci N., Scarabino T., Weinberger D.R., and Nardini M. Hippocampal neurochemcial pathology in patients at first episode of affective psychosis: a proton magnetic resonance spectroscopic imaging study. Psychiatry Research Neuroimaging 131 (2004) 95-105
5. 1H magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in bipolar disorder patients. Journal of Affective Disorders 86 (2005) 61-67
6. 18F]2-deoxyglucose in affective illness. Journal of Affective Disorders 10 (1986) 137-152
7. Callicott J.H., Bertolino A., Mattay V.S., Langheim F.J.P., and Weinberger D.R. Selective relationship between NAA measure and negative symptoms in schizophrenia. American Journal of Psychiatry 157 (2000) 1646-1651
8. Cecil K.M., Del Bello M.P., Morey R., and Strakowski S.M. Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy. Bipolar Disorders 4 (2002) 357-365
9. Cecil K.M., Del Bello M.P., Sellars M.C., and Strakowski S.M. Proton magnetic resonance spectroscopy of the frontal lobe and cerebellar vermies in children with a mood disorder and a familial risk for bipolar disorder. Journal of Child and Adolescent Psychopharmacology 13 (2003) 545-555
10. Chang K., Adleman N., Dienes K., Barnea-Goraly N., Reiss A., and Ketter T. Decreased N-acetylaspartate in children with familial bipolar disorder. Biological Psychiatry 53 (2003) 1059-1065
11. Davanzo P., Thomas M.A., Yue K., Oshiro T., Belin T., Strober M., and McCracken J. Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder. Neuropsychopharmacology 24 (2001) 359-369
12. Deicken R.F., Eliaz Y., Feiwell R., and Schuff N. Increased thalamic N-acetylaspartate in male patients with familial bipolar I disorder. Psychiatry Research: Neuroimaging 106 (2001) 35-45
13. Deicken R.F., Pegues M.P., Anzalone S., Feiwell R., and Soher B. Lower concentration of hippocampal N-acetylaspartate in familial bipolar I disorder. American Journal of Psychiatry 160 (2003) 873-882
14. Demougeot C., Garnier P., Mossiat C., Betrand N., Giroud M., Beley A., and Marie C. N-acetylaspartate, a marker of both cellular dysfunction and neuronal loss: its relevance to studies of acute brain injury. Journal of Neurochemistry 77 (2001) 408-415
15. Drevets W.C., and Raichle M.E. Neuroanatomical circuits in depression: implications for treatment mechanisms. Psychopharmacology Bulletin 28 (2002) 261-274
16. Dupont R.M., Jernigan T.L., Butters N., Delis D., Hesselink J.R., Heindel W., and Gillin J.C. Subcortical abnormalities detected in bipolar disorder using magnetic resonance imaging. Archives of General Psychiatry 47 (1990) 55-59
17. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version, Patient Edition (SCID-I/P) (1997), Biometrics Research, New York State Psychiatric Institute, New York, NY
18. Frahm J., Bruhn H., Gyngell M.L., Merboldt K.D., Hanicke W., and Sauter R. Localized high-resolution proton NMR spectroscopy using stimulated echoes; initial applications to human brain in vivo. Magnetic Resonance in Medicine 9 (1989) 79-93
19. 1H NMR chemical shift selective (CHESS) imaging. Physics in Medicine and Biology 30 (1985) 341-344
20. Hamakawa H., Kato T., Murashita J., and Kato N. Quantitative proton magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders. European Archives of Psychiatry and Clinical Neuroscience 248 (1998) 53-58
21. Kato T., Hamakawa H., Shioiri T., Murashita J., Takahashi Y., Takahashi S., and Inubushi T. Choline-containing compounds detected by proton magnetic resonance spectroscopy in the basal ganglia in bipolar disorder. Psychiatric Neuroscience 21 (1996) 248-254
22. Mai J.K., Assheuer J., and Paxinos G. Atlas of the Human Brain vol. viii (1997), Academic Press, San Diego 328
23. Mega M.S., and Cummings J.L. Frontal-subcortical circuits and neuropsychiatric disorders. Journal of Neuropsychiatry and Clinical Neuroscience 6 (1994) 358-370
24. Moore G.J., and Galloway M. Magnetic resonance spectroscopy: neurochemistry and treatment effects in affective disorders. Psychopharmacology Bulletin 36 (2002) 5-23
25. Moore G.J., Bebchuck J.M., Wilds I.B., Chen G., and Manji H.K. Lithium-induced increase in human brain grey matter. Lancet 356 (2000) 1241-1242
26. Ohara K., Isoda H., Suziki Y., Takehara Y., Ochiai M., Takeda H., Igarashi Y., and Ohara K. Proton magnetic resonance spectroscopy of the lenticular nuclei in bipolar I affective disorder. Psychiatry Research: Neuroimaging 84 (1998) 55-60
27. Ongur D., Drevets E.W.C., and Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proceedings of the National Academy of Sciences of the United States of America 95 (1998) 13290-13295
28. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magnetic Resonance in Medicine 30 (1993) 672-679
29. 1H spectra with LC Model. NMR in Biomedicine 14 (2001) 260-264
30. Rajkowska G., Halaris A., and Selemon L.D. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biological Psychiatry 49 (2001) 741-752
31. Sharma R., Venkatasubramanian P.N., Bárány M., and Davis J.M. Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients. Schizophrenia Research 8 (1992) 42-43
32. Silverstone P.H., Wu R.H., O'Donnell T., Ulrich M., Asghar S.J., and Hanstock C.C. Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetylaspartate concentrations in euthymic bipolar patients. International Clinical Psychopharmacology 18 (2003) 73-79
33. Soares J.C., and Mann J.J. The functional neuroanatomy of mood disorders. Journal of Psychiatric Research 31 (1997) 393-432
34. Stanley J.A. In vivo magnetic resonance spectroscopy and its application to neuropsychiatric disorders. Canadian Journal of Psychiatry 47 (2002) 315-326
35. Stoll A., Renshaw P.F., Yurgelun-Todd D.A., and Cohen B.M. Neuroimaging in bipolar disorder: what have we learned?. Biological Psychiatry 48 (2000) 505-517
36. Strakowski S.M., DelBello M.P., and Adler C.M. The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. Molecular Psychiatry 10 (2005) 105-116
37. Tsai G., and Coyle J.T. N-acetylaspartate in neuropsychiatric disorders. Progress in Neurobiology 46 (1995) 531-540
38. Winsberg M.E., Sachs N., Tate D.L., Adalsteinsson E., Spielman D., and Ketter T.A. Decreased dorsolateral prefrontal N-acetylaspartate in bipolar disorder. Biological Psychiatry 47 (2000) 475-481
39. Young R.C., Biggs J.T., Ziegler V.E., and Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry 133 (1978) 429-435